Investment House LLC Sells 1,350 Shares of The Clorox Company (NYSE:CLX)

Investment House LLC reduced its stake in shares of The Clorox Company (NYSE:CLX) by 32.5% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,810 shares of the company’s stock after selling 1,350 shares during the period. Investment House LLC’s holdings in Clorox were worth $456,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently made changes to their positions in the company. OneDigital Investment Advisors LLC acquired a new stake in Clorox in the 3rd quarter worth approximately $207,000. Natixis Advisors LLC boosted its holdings in shares of Clorox by 8.3% during the 3rd quarter. Natixis Advisors LLC now owns 63,476 shares of the company’s stock worth $10,341,000 after buying an additional 4,839 shares during the period. Thrivent Financial for Lutherans raised its holdings in Clorox by 2.7% in the 3rd quarter. Thrivent Financial for Lutherans now owns 9,091 shares of the company’s stock worth $1,481,000 after acquiring an additional 236 shares during the period. Swiss National Bank lifted its position in Clorox by 0.3% during the 3rd quarter. Swiss National Bank now owns 368,600 shares of the company’s stock worth $60,049,000 after acquiring an additional 1,200 shares during the last quarter. Finally, MAI Capital Management boosted its holdings in Clorox by 2.1% during the third quarter. MAI Capital Management now owns 12,918 shares of the company’s stock valued at $2,104,000 after acquiring an additional 260 shares during the period. Institutional investors and hedge funds own 78.53% of the company’s stock.

Clorox Trading Up 0.3 %

CLX stock opened at $145.33 on Thursday. The Clorox Company has a 1-year low of $127.60 and a 1-year high of $171.37. The company has a current ratio of 0.94, a quick ratio of 0.60 and a debt-to-equity ratio of 20.52. The business’s 50 day moving average is $153.40 and its 200-day moving average is $159.97. The firm has a market cap of $17.90 billion, a P/E ratio of 39.71, a P/E/G ratio of 2.62 and a beta of 0.45.

Clorox (NYSE:CLX) last announced its quarterly earnings results on Monday, February 3rd. The company reported $1.55 earnings per share for the quarter, beating analysts’ consensus estimates of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same period in the previous year, the business earned $2.16 EPS. Equities analysts anticipate that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, May 9th. Investors of record on Wednesday, April 23rd will be issued a dividend of $1.22 per share. This represents a $4.88 annualized dividend and a yield of 3.36%. The ex-dividend date of this dividend is Wednesday, April 23rd. Clorox’s dividend payout ratio is currently 133.33%.

Analyst Ratings Changes

Several equities analysts recently weighed in on CLX shares. JPMorgan Chase & Co. boosted their price objective on Clorox from $171.00 to $173.00 and gave the stock a “neutral” rating in a research report on Tuesday, February 4th. DA Davidson reduced their price objective on Clorox from $171.00 to $169.00 and set a “neutral” rating for the company in a research report on Wednesday, February 5th. Barclays boosted their target price on shares of Clorox from $130.00 to $140.00 and gave the stock an “underweight” rating in a research report on Wednesday, February 5th. Evercore ISI increased their price target on shares of Clorox from $145.00 to $155.00 in a report on Tuesday, February 4th. Finally, Wells Fargo & Company boosted their price objective on shares of Clorox from $157.00 to $161.00 and gave the stock an “equal weight” rating in a report on Tuesday, February 4th. Three research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and one has assigned a buy rating to the stock. Based on data from MarketBeat.com, Clorox has a consensus rating of “Hold” and a consensus price target of $159.62.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.